Daxor Corporation Announces That Shertech Pharmacy Acquires BVA-100 Blood Volume Analyzer

NEW YORK, NY--(Marketwire - March 23, 2012) -

Highlighted Links

www.daxor.com

Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Shertech Pharmacy in Charlotte, North Carolina. This agreement will provide Shertech with a Daxor BVA-100 Blood Volume Analyzer, an instrument which enables semi-automated measurement of a patient's total blood volume, red blood cell volume and plasma volume. Blood volume abnormalities are observed in a variety of cardiac conditions and have been associated with poor prognosis. Published studies using the BVA-100 have shown that blood volume measurement is important in treating heart failure, critical care patients in intensive care units, and in diagnosing the true status of complex anemias and syncope (fainting).

Shertech Pharmacy is an independently owned specialty radiopharmacy with facilities in North and South Carolina and was founded in 1991. Shertech provides radio nuclear medical services to over 60 hospitals (the smallest being a 60-bed facility and the largest being an 890-bed facility) in the North and South Carolina areas. The Daxor BVA-100 will be housed at the Greenville Memorial Hospital in Greenville, SC. The medical community and retail public in the region rely on the friendly, well-trained staff to provide the highest quality nuclear pharmaceuticals and specialty compounding services.

Shertech pharmacists and technicians are entirely committed to providing the best possible solutions and quality care to customers and their patients. They have continuous courier services between their facilities, allowing for prompt delivery of blood to be processed at the Greenville Memorial site. They have arranged for an "on call" setup for emergencies occurring between the hours of 12:00 a.m. and 6:00 a.m. Shertech's commitment to life-long learning, research, and continuing education assures each patient that the most current and accurate methods are used to provide the medicine they require. These pharmacists are experts in their field, and work in cooperation with local hospitals and physicians in research studies and medical trials to help develop even better medical analyses and outcomes for patients. The staff members recognize the uniqueness of every customer and individually tailor service to fit each patient's needs. Richard Sheriff, Nuclear Pharmacist, President and Owner of Shertech Pharmacy said, "Shertech Nuclear Pharmacy is based on high standards of integrity and a desire to advance our technology. The Daxor Blood Volume analysis method not only allowed us to meet customer needs, but to also improve patient outcomes with advanced testing methods and results. Shertech Pharmacy was already a CLIA approved Laboratory; the Daxor BVA method allowed us to expand our products and service offering to our customers and to provide a more in depth clinical report."

Daxor Corporation manufactures and markets the BVA-100, which is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website at www.Daxor.com.